Compare AMRX & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | MRCY |
|---|---|---|
| Founded | 2002 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.3B |
| IPO Year | 2018 | 1997 |
| Metric | AMRX | MRCY |
|---|---|---|
| Price | $18.68 | $99.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $15.60 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 1.8M | 620.6K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | 72.69 |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | ★ $912,020,000.00 |
| Revenue This Year | $4.48 | $6.59 |
| Revenue Next Year | $7.13 | $9.56 |
| P/E Ratio | $95.21 | ★ N/A |
| Revenue Growth | N/A | ★ 9.19 |
| 52 Week Low | $7.67 | $50.13 |
| 52 Week High | $18.39 | $128.45 |
| Indicator | AMRX | MRCY |
|---|---|---|
| Relative Strength Index (RSI) | 70.49 | 44.23 |
| Support Level | $12.46 | $70.51 |
| Resistance Level | N/A | $103.81 |
| Average True Range (ATR) | 0.56 | 5.63 |
| MACD | -0.01 | -0.42 |
| Stochastic Oscillator | 96.30 | 30.99 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.